GlassScriptPhysician profile
May-Thu Hung
NPI 1760067714
$2,368.18
in general payments reported to CMS, 2019-2025
11 companies · $460 in 2025
The $460 reported for 2025 was more than what a typical Family provider received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $209 · 2022: $543 · 2023: $653 · 2024: $503 · 2025: $460.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,617.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,616.50 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sumitomo Pharma America, INC. | $867.21 | 2023-2025 | Gemtesa |
| Astellas Pharma US INC | $646.53 | 2021-2024 | Myrbetriq, Veozah |
| Axonics, INC. | $222.13 | 2022-2024 | Axonics |
| Urovant Sciences INC | $158.17 | 2021-2022 | |
| Pfizer INC. | $139.15 | 2022-2024 | |
| 180 Medical, INC. | $115.77 | 2021-2025 | Gentlecath |
| Convatec INC. | $108.24 | 2021-2023 | |
| Millicent US INC | $59.16 | 2023-2024 | Femring, Intrarosa |
| Hollister Incorporated | $22.60 | 2021 | |
| Exact Sciences Corporation | $15.04 | 2023 | Cologuard Collection Kit |
| Hologic Sales and Service, LLC | $14.18 | 2024 | Myosure Tissue Removal Device, Novasure, Acessa Provu System |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw May-Thu Hung listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.